Synonyms: BOL-303242-X | ZK-245186 | ZK245186
Compound class:
Synthetic organic
Comment: Mapracorat is a novel non-steroidal selective glucocorticoid receptor agonist (SEGRA) [3-4]. SEGRAs exert their pharmacological effect by activating only the transrepression pathway, which is in contrast to traditional glucocorticosteroids (GCs) which activate both the transactivation and transrepression pathways.The pharmaceutical industry is trying to develop new GCs that are as effective as traditional GCs, but with fewer limiting adverse effects. Mapracorat and GSK866 are prototype compounds that were designed to address this clinical need.
|
|
Classification | |
Compound class | Synthetic organic |
International Nonproprietary Names | |
INN number | INN |
9214 | mapracorat |
Synonyms |
BOL-303242-X | ZK-245186 | ZK245186 |
Database Links | |
CAS Registry No. | 887375-26-0 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL2103876 |
GtoPdb PubChem SID | 340590284 |
PubChem CID | 24795088 |
Search Google for chemical match using the InChIKey | VJGFOYBQOIPQFY-XMMPIXPASA-N |
Search Google for chemicals with the same backbone | VJGFOYBQOIPQFY |
Search PubMed clinical trials | mapracorat |
Search PubMed titles | mapracorat |
Search PubMed titles/abstracts | mapracorat |
UniChem Compound Search for chemical match using the InChIKey | VJGFOYBQOIPQFY-XMMPIXPASA-N |
UniChem Connectivity Search for chemical match using the InChIKey | VJGFOYBQOIPQFY-XMMPIXPASA-N |